ATE400572T1 - Verfahren zur herstellung von rosiglitazon - Google Patents

Verfahren zur herstellung von rosiglitazon

Info

Publication number
ATE400572T1
ATE400572T1 AT05773498T AT05773498T ATE400572T1 AT E400572 T1 ATE400572 T1 AT E400572T1 AT 05773498 T AT05773498 T AT 05773498T AT 05773498 T AT05773498 T AT 05773498T AT E400572 T1 ATE400572 T1 AT E400572T1
Authority
AT
Austria
Prior art keywords
rosiglitazone
producing
formula
reduction
yridyl
Prior art date
Application number
AT05773498T
Other languages
English (en)
Inventor
Ales Halama
Petr Lustig
Josef Jirman
Original Assignee
Zentiva As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentiva As filed Critical Zentiva As
Application granted granted Critical
Publication of ATE400572T1 publication Critical patent/ATE400572T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
AT05773498T 2004-09-10 2005-08-31 Verfahren zur herstellung von rosiglitazon ATE400572T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CZ20040956A CZ297266B6 (cs) 2004-09-10 2004-09-10 Zpusob prípravy rosiglitazonu

Publications (1)

Publication Number Publication Date
ATE400572T1 true ATE400572T1 (de) 2008-07-15

Family

ID=35520549

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05773498T ATE400572T1 (de) 2004-09-10 2005-08-31 Verfahren zur herstellung von rosiglitazon

Country Status (6)

Country Link
EP (1) EP1786808B1 (de)
AT (1) ATE400572T1 (de)
CZ (1) CZ297266B6 (de)
DE (1) DE602005008076D1 (de)
EA (1) EA200700568A1 (de)
WO (1) WO2006026934A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1887006A1 (de) * 2006-08-07 2008-02-13 Krka Polymorphe Formen von Rosiglitazon- Base

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0306228B1 (de) * 1987-09-04 1999-11-17 Beecham Group Plc Substituierte Thiazolidindionderivate
CA2122712C (en) * 1991-12-20 1999-09-21 Joel Edward Huber A reduction method for substituted 5-methylene-thiazolidinediones
UY24886A1 (es) * 1997-02-18 2001-08-27 Smithkline Beecham Plc Tiazolidindiona
GB9723295D0 (en) * 1997-11-04 1998-01-07 Smithkline Beecham Plc Novel process
WO2003029251A1 (en) * 2001-09-28 2003-04-10 Biocon Limited Novel process for the synthesis of thiazolidinedione derivatives
EP1521753B1 (de) * 2002-07-16 2007-09-05 Cadila Healthcare Ltd. Prozess zur herstellung von pioglitazon via verschiedene zwischenstufen
GB2405403A (en) * 2003-08-29 2005-03-02 Cipla Ltd Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base
EP1709038A2 (de) * 2004-01-28 2006-10-11 Usv Limited Verfahren zur herstellung von 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]phenylmethyl]thiazolidin-2,4-dionmaleat

Also Published As

Publication number Publication date
EP1786808A1 (de) 2007-05-23
CZ2004956A3 (cs) 2006-04-12
EP1786808B1 (de) 2008-07-09
DE602005008076D1 (de) 2008-08-21
CZ297266B6 (cs) 2006-10-11
EA200700568A1 (ru) 2007-08-31
WO2006026934A1 (en) 2006-03-16

Similar Documents

Publication Publication Date Title
UA92354C2 (en) Amino acid salts of rosiglitazone
WO2005080358A3 (en) Rosiglitazone phosphate and polymorphic forms
WO2009025983A3 (en) Method for preparing 5-haloalkyl-4,5-dihydroisoxazole derivatives
DK1701722T3 (da) N-Hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy} benzamidin-2-methansulfonsyresalt
CY1107238T1 (el) Παρασκευη μιας πολυμορφικης μορφης ενος παραγωγου θειαζολιδινοδιονης
AR055112A1 (es) Fungicidas n-(2-(haloalcoxi) fenil) heteroaril carboxamidas
DZ3316A1 (de) Hcl-salze von 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidin-2,4-dion
CL2008002142A1 (es) Compuestos derivados de 2-amino-6-({[2-(4-clorofenil)-1,3-tiazol-4-il]metil}tio)-4-[4-(2-hidroxietoxi) fenil] piridin-3,5-dicarbonitrilo; procedimiento de preparacion; composicion farmaceutica y uso en enfermedades cardiovasculares.
EA200701680A1 (ru) Лекарственная форма для перорального введения, содержащая розиглитазон
WO2009018065A3 (en) Novel glucokinase activators and methods of using same
NO20031356L (no) Nye polymorfe former av 5-[4-[2-[N-metyl-N-(2- pyridyl]amino]etoksy]benzyl]tiazolidin-2,4-dionmaleat og fremgangsmåte for fremstilling avsamme
ATE400572T1 (de) Verfahren zur herstellung von rosiglitazon
EP1302467A3 (de) Verfahren zur Herstellung von substituierten Thiazolinen und deren Zwischenprodukte
EA200300345A1 (ru) Гидрохлоридная соль 5-[4-[2-(n-метил-n-(2-пиридил)амино)этокси]бензил]тиазолидин-2,4-диона
ATE329914T1 (de) Rosiglitazon-edisylate und ihre verwendung als antidiabetika
ATE488515T1 (de) Rosiglitazonhydrochlorid-hemihydrat
AU2003269483A1 (en) Phosphoric acid salt of 5-((4-(2-(methyl-2-pyridinylamino) ethoxy) phenyl) methyl)- 2,4-thiazolidinedione
WO2005021542A3 (en) Process for the preparation of pioglitazone
ATE310000T1 (de) Ein thiazolidindionderivat und seine verwendung als antidiabetikum
DE60124119D1 (de) Ein thiazolidindionderivat und seine verwendung als antidiabetikum
EA200700003A1 (ru) Соль фосфорной кислоты и 5-[4-[2-(n-метил-n-(2-пиридил)амино)этокси]бензил]тиазолидин-2,4-диона и способ её получения
WO2008010089A3 (en) Process for preparation of intermediates of rosiglitazone, rosiglitazone and polymorphic forms thereof
NO20092362L (no) 2-N-(5-[{4-(2-(metyl-2-pyridinylamino) etoksy] fenyl]metyl}2,4-tiazolidinedion) butanedisyre, fremgangsmater for fremstilling og sammensetninger med rosiglitazon maleat
DE602004015784D1 (de) Verkapselte materialien
EA200900725A1 (ru) Полиморфы гидробромида 5-{2-[4-(1,2-бензоизотиазол-3-ил)-1-пиперазинил]этил}-6-хлор-1,3-дигидро-2н-индол-2-она и способы их получения

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties